CD123-positive plasmacytoid dendritic cells in primary cutaneous marginal zone B-cell lymphoma: diagnostic and

Heinz Kutzner1, Helmut Kerl, Monique C Pfaltz

  • 1Dermatopathologie, Friedrichshafen, Germany.

Insights

Plasma-cytoid dendritic cells (PDC) are significantly present in primary cutaneous marginal zone B-cell lymphoma (PCMZL), suggesting a role in its development and offering a diagnostic marker. This finding helps understand PCMZL

Area of Science:

  • Dermatology
  • Immunology
  • Oncology

Background:

  • The origin of primary cutaneous marginal zone B-cell lymphoma (PCMZL) remains unclear.
  • Plasma-cytoid dendritic cells (PDC) are vital for initiating immune responses and activating lymphocytes.
  • Understanding the cellular components of PCMZL is crucial for diagnosis and understanding its pathogenesis.

Purpose of the Study:

  • To investigate the presence and distribution of PDC in various primary cutaneous B-cell lymphomas and pseudolymphomas.
  • To determine if PDC clusters can serve as a diagnostic marker for PCMZL.
  • To explore the potential role of PDC in the pathogenesis of PCMZL.

Main Methods:

  • Immunohistochemistry was used to detect and quantify CD123+ PDC.
  • Analysis included cases of PCMZL, cutaneous B-cell pseudolymphomas, primary cutaneous follicle center lymphoma, and primary cutaneous diffuse large B-cell lymphoma, leg type.
  • PDC presence was correlated with lymphoma type, cellular proximity, and disease stage.

Main Results:

  • Abundant PDC clusters were found in all PCMZL cases (100%) and a majority of pseudolymphomas (64%).
  • PDC were largely absent in other B-cell lymphoma subtypes studied.
  • PDC clusters were located near malignant plasma cells and T-cells, even in early disease stages.

Conclusions:

  • The presence of large PDC clusters is a useful diagnostic aid for PCMZL.
  • PDC likely play a significant role in the development of PCMZL.
  • PCMZL may be an antigen-driven malignancy involving PDC, T-cells, and B-cells.

Related Concept Videos